title: [Carcinoid tumors].
abstract: Carcinoids are characteristically indolent, but heterogeneous tumors with respect to their site of origin, endocrine features, clinical manifestations and biologic behaviour. The authors summarize the current laboratory, endoscopic and radiologic methods used for the diagnosis of carcinoid tumors. Treatment modalities should be directed against the tumor and the hormonal excess state. The authors review the outcome of most frequently used therapies, including somatostatin-analogue and interferon treatment, chemotherapy, embolization, receptor-targeted radiotherapy and surgical intervention). Patients with carcinoid tumors, with or without carcinoid syndrome, are best managed by a multidisciplinary approach.
authors.forename: Miklós
authors.initials: M
authors.lastname: Tóth
authors.forename: László
authors.initials: L
authors.lastname: Prónai
authors.forename: Anna Mária
authors.initials: AM
authors.lastname: Németh
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Tulassay
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002275:Carcinoid Heart Disease / Q000175:diagnosis / Q000628:therapy; D002276:Carcinoid Tumor / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008303:Malignant Carcinoid Syndrome / Q000175:diagnosis / Q000628:therapy; D015282:Octreotide / Q000627:therapeutic use; D011868:Radioisotopes / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha; D011868:Radioisotopes; D015282:Octreotide
vernacular_title: Carcinoid tumorok.